Acetylcholineestarase-Inhibiting Alkaloids from Lycoris radiata Delay Paralysis of Amyloid Beta-Expressing Transgenic C. elegans CL4176

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Xin, Lijuan ^a,d   Yamujala, Ritupriya ^b   Wang, Yuehu ^c   Wang, Huan ^c   Wu, Wen Hsuan ^b   Lawton, Michael A ^d   Long, Chunlin ^a,c   Di, Rong ^d  

^a MINZU UNIVERSITY OF CHINA   (China)

^b University of Medicine and Dentistry of New Jersey   (United States)

^c KUNMING INSTITUTE OF BOTANY   (China)

^d The State University of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O ACETYLLYCORINE; 1,2 DI O ACETYLLYCORINE; ACETYLCHOLINESTERASE; ALKALOID DERIVATIVE; AMYLOID BETA PROTEIN; CHOLINESTERASE INHIBITOR; GALANTAMINE; HAEMANTHIDINE; MEMANTINE; UNCLASSIFIED DRUG;

ACE 1 GENE; ACE 2 GENE; ANTIOXIDANT ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG ISOLATION; DRUG SYNTHESIS; ENZYME INHIBITION; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LIFESPAN; LYCORIS; LYCORIS RADIATA; NONHUMAN; PARALYSIS; PROTEIN EXPRESSION; STRESS; SURVIVAL RATE; TEMPERATURE DEPENDENCE; TRANSGENIC ORGANISM;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; AMARYLLIDACEAE ALKALOIDS; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CAENORHABDITIS ELEGANS; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; GALANTAMINE; GENE EXPRESSION; HUMANS; LONGEVITY; LYCORIS; OXIDATIVE STRESS; PARALYSIS; PEPTIDE FRAGMENTS; PHENANTHRIDINES;

EID: 84877660759     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063874     Document Type: Article

References (37)

1. Goedert M, Spillantini MG, (2006) A century of Alzheimer's disease. Science 314: 777-781.
2. Monsonego A, Maron R, Zota V, Selkoe DJ, Weiner HL, (2001) Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease. Proc Natl Acad Sci U S A 98: 10273-10278.
3. Hardy J, Selkoe DJ, (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356.
4. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, et al. (2010) Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330: 1774.
5. Bartus RT, Dean RL 3rd, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-414.
6. McGleenon BM, Dynan KB, Passmore AP, (1999) Acetylcholinesterase inhibitors in Alzheimer's disease. Br J Clin Pharmacol 48: 471-480.
7. Tabet N, (2006) Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing! Age Ageing. 35: 336-338.
8. Wenk GL, Quack G, Moebius HJ, Danysz W, (2000) No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use. Life Sci 66: 1079-1083.
9. Wang H, Wang YH, Zhao FW, Huang QQ, Xu JJ, et al. (2011) Benzylphenethylamine alkaloids from the bulbs and flowers of Lycoris radiata. Chin Herbal Mediciens 3: 60-63.
10. Geng ZF, Lv HS, Zhang MH, (2008) Supercritical CO2 extraction technology of lycorenine in L. radiata. Chin Tradit Herb Drugs 39: 543-546.
11. Wang L, Zhang XQ, Yin ZQ, Wang Y, Ye WC, (2009) Two new amaryllidaceae alkaloids from the bulbs of Lycoris radiata. Chem Pharm Bull (Tokyo) 57: 610-611.
12. Howes MJ, Houghton PJ, (2003) Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 75: 513-527.
13. Giunta B, Ehrhart J, Townsend K, Sun N, Vendrame M, et al. (2004) Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Res Bull 64: 165-170.
14. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421: 384-388.
15. Reale M, Iarlori C, Gambi F, Lucci I, Salvatore M, et al. (2005) Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients. Exp Gerontol 40: 165-171.
16. Zhang HY, Tang XC, (2000) Huperzine B, a novel acetylcholinesterase inhibitor, attenuates hydrogen peroxide induced injury in PC12 cells. Neurosci Lett 292: 41-44.
17. Wang R, Zhou J, Tang XC, (2002) Tacrine attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells. Brain Res Mol Brain Res 107: 1-8.
18. Xiao XQ, Wang R, Tang XC, (2000) Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury. J Neurosci Res 61: 564-569.
19. Link CD, (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A 92: 9368-9372.
20. Link CD, (2006) C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease. Exp Gerontol 41: 1007-1013.
21. Gutierrez-Zepeda A, Santell R, Wu Z, Brown M, Wu Y, et al. (2005) Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci 6: 54.
22. Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, et al. (2006) Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 26: 13102-13113.
23. Arya U, Dwivedi H, Subramaniam JR, (2009) Reserpine ameliorates Abeta toxicity in the Alzheimer's disease model in Caenorhabditis elegans. Exp Gerontol 44: 462-466.
24. Elgorashi EE, Stafford GI, Van Staden J, (2004) Acetylcholinesterase enzyme inhibitory effects of amaryllidaceae alkaloids. Planta Med 70: 260-262.
25. Dostal V, Link CD (2010) Assaying beta-amyloid toxicity using a transgenic C. elegans model. JoVe. doi: 10.3791/2252.
26. Drake J, Link CD, Butterfield DA, (2003) Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol Aging 24: 415-420.
27. Hatters DM, Griffin MDW (2011) Diagnostics for amyloid fibril formation: where to begin? Secaucus, NJ, Springer Science+Business Media, LLC.
28. Link CD, Taft A, Kapulkin V, Duke K, Kim S, et al. (2003) Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model. Neurobiol Aging 24: 397-413.
29. Combes D, Fedon Y, Toutant JP, Arpagaus M, (2001) Acetylcholinesterase genes in the nematode Caenorhabditis elegans. Int Rev Cytol 209: 207-239.
30. Culetto E, Combes D, Fedon Y, Roig A, Toutant JP, et al. (1999) Structure and promoter activity of the 5′ flanking region of ace-1, the gene encoding acetylcholinesterase of class A in Caenorhabditis elegans. J Mol Biol 290: 951-966.
31. Combes D, Fedon Y, Toutant JP, Arpagaus M, (2003) Multiple ace genes encoding acetylcholinesterases of Caenorhabditis elegans have distinct tissue expression. Eur J Neurosci 18: 497-512.
32. Selkirk ME, Lazari O, Hussein AS, Matthews JB, (2005) Nematode acetylcholinesterases are encoded by multiple genes and perform non-overlapping functions. Chem Biol Interact 157-158: 263-268.
33. Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, et al. (1995) Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 92: 9328-9332.
34. Evidente A, Kireev AS, Jenkins AR, Romero AE, Steelant WF, et al. (2009) Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Med 75: 501-507.
35. Evidente A, Komienko A, (2009) Anticancer evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives. Phytochem Rev 8: 449-459.
36. Nakagawa Y, Uyeo S, Yajima H, (1956) The double bond in lycorine. Chemistry and Industry 16: 1238-1239.
37. Lee SS, Venkatesham U, Rao CP, Lam SH, Lin JH, (2007) Preparation of secolycorines against acetylcholinesterase. Bioorg Med Chem 15: 1034-1043.